SG11201810254UA - Blood sample analysis method and system, for determining diabetes - Google Patents

Blood sample analysis method and system, for determining diabetes

Info

Publication number
SG11201810254UA
SG11201810254UA SG11201810254UA SG11201810254UA SG11201810254UA SG 11201810254U A SG11201810254U A SG 11201810254UA SG 11201810254U A SG11201810254U A SG 11201810254UA SG 11201810254U A SG11201810254U A SG 11201810254UA SG 11201810254U A SG11201810254U A SG 11201810254UA
Authority
SG
Singapore
Prior art keywords
blood sample
sample analysis
analysis method
diabetes
diabetes complications
Prior art date
Application number
SG11201810254UA
Other languages
English (en)
Inventor
Yoshitaka Isaka
Tomonori Kimura
Keiko Yasuda
Kenji Hamase
Masashi Mita
Original Assignee
Univ Osaka
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Osaka, Shiseido Co Ltd filed Critical Univ Osaka
Publication of SG11201810254UA publication Critical patent/SG11201810254UA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7042—Aging, e.g. cellular aging

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG11201810254UA 2016-05-17 2017-05-17 Blood sample analysis method and system, for determining diabetes SG11201810254UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016099163 2016-05-17
PCT/JP2017/018592 WO2017200025A1 (fr) 2016-05-17 2017-05-17 Procédé et système d'analyse d'échantillon de sang pour déterminer le diabète

Publications (1)

Publication Number Publication Date
SG11201810254UA true SG11201810254UA (en) 2018-12-28

Family

ID=60326004

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201810254UA SG11201810254UA (en) 2016-05-17 2017-05-17 Blood sample analysis method and system, for determining diabetes

Country Status (8)

Country Link
US (1) US20190271708A1 (fr)
EP (1) EP3460478A4 (fr)
JP (2) JP6609282B2 (fr)
CN (1) CN109154619A (fr)
AU (1) AU2017266331A1 (fr)
IL (1) IL263024A (fr)
SG (1) SG11201810254UA (fr)
WO (1) WO2017200025A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019235591A1 (fr) * 2018-06-07 2019-12-12 国立大学法人金沢大学 Biomarqueur d'état pathologique pour une maladie rénale
CN113196063A (zh) * 2018-10-17 2021-07-30 镜株式会社 用于判定危险期的肾损伤的标志物
JPWO2020196436A1 (fr) * 2019-03-22 2020-10-01
JPWO2020196437A1 (fr) * 2019-03-22 2020-10-01
CN114113349B (zh) * 2020-08-26 2024-01-23 湖南农业大学 一种基于二维液相色谱-紫外衍生法同时测定生物基质中5种氨基酸类神经递质的方法
JPWO2022244842A1 (fr) * 2021-05-19 2022-11-24

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI351278B (en) * 2002-03-01 2011-11-01 Nisshin Pharma Inc Agent for preventing and treating of liver disease
EP1837657A1 (fr) * 2006-03-24 2007-09-26 Metanomics GmbH Moyens et procédé pour prédire ou diagnostiquer un diabète
ATE493661T1 (de) * 2006-03-24 2011-01-15 Metanomics Gmbh Mittel und verfahren zur prognose oder diagnose von diabetes typ ii
US20080026378A1 (en) * 2006-07-28 2008-01-31 Gian Franco Bottazzo Prediction and prophylactic treatment of type 1 diabetes
US20100273661A1 (en) * 2007-06-15 2010-10-28 Smithkline Beecham Corporation Methods and Kits for Predicting Treatment Response in Type II Diabetes Mellitus Patients
JP5517931B2 (ja) * 2007-06-29 2014-06-11 クエスト ダイアグノスティックス インヴェストメンツ インコーポレイテッド 液体クロマトグラフィー質量分析による体液中のアミノ酸分析
WO2011034088A1 (fr) * 2009-09-16 2011-03-24 旭化成ファーマ株式会社 Procédé d'identification et procédé de prédiction de la survenue d'un infarctus cérébral athérothrombotique dans un infarctus cérébral aigu
JP2011092100A (ja) * 2009-10-29 2011-05-12 Dna Chip Research Inc 生理的状態変化と生理的状態に変化を与える要因の効果を評価する遺伝子マーカー、評価方法、評価システム、及びコンピュータプログラム
WO2012164525A2 (fr) * 2011-06-01 2012-12-06 Ecole Polytechnique Federale De Lausanne (Epfl) Biomarqueurs de vieillissement
CN114966050A (zh) * 2012-03-18 2022-08-30 镜株式会社 疾病样品分析装置、分析系统及分析方法
CA2917414C (fr) * 2012-07-30 2021-09-14 In Ovo B.V. Determination du genre, de la viabilite et/ou du stade de developpement d'embryons aviaires in ovo
CN102901789A (zh) * 2012-09-21 2013-01-30 中国药科大学 糖尿病肾病早期诊断的血清代谢标志物测定方法
JP6404834B2 (ja) * 2013-01-31 2018-10-17 メタボロン，インコーポレイテッド インスリン抵抗性の進行に関連するバイオマーカー及びこれを使用する方法
JP5740523B1 (ja) * 2013-12-11 2015-06-24 株式会社 資生堂 腎不全の早期診断マーカー
CN106537145B (zh) * 2014-04-08 2020-08-25 麦特博隆股份有限公司 用于疾病诊断和健康评估的个体受试者的小分子生物化学特征分析

Also Published As

Publication number Publication date
EP3460478A1 (fr) 2019-03-27
JP2017207490A (ja) 2017-11-24
WO2017200025A1 (fr) 2017-11-23
AU2017266331A1 (en) 2018-12-06
JP6884346B2 (ja) 2021-06-09
EP3460478A4 (fr) 2020-01-08
US20190271708A1 (en) 2019-09-05
IL263024A (en) 2018-12-31
AU2017266331A8 (en) 2018-12-20
JP6609282B2 (ja) 2019-11-20
CN109154619A (zh) 2019-01-04
JP2019191192A (ja) 2019-10-31

Similar Documents

Publication Publication Date Title
SG11201810254UA (en) Blood sample analysis method and system, for determining diabetes
EA201891293A1 (ru) Мультиспецифические антитела
BR112017004379A2 (pt) determinação de vivacidade em multi-estágio
EA201891292A1 (ru) Мультиспецифические антитела
EP3757225A3 (fr) Kit ou dispositif de détection du cancer du pancréas et procédé de détection
EP3816303A3 (fr) Kit ou dispositif de détection du cancer du sein et procédé de détection du cancer du sein
BR112017018821A2 (pt) métodos para quantificação de níveis de insulina através de espectrometria de massa
BR112018069849A2 (pt) kit, dispositivo e método para a detecção de câncer pancreático precoce ou de lesão precursora do câncer pancreático
PH12019502558A1 (en) Diagnostic assays for detecting, quantifying, and/or tracking microbes and other analytes
PH12015502849A1 (en) Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers
EP3967769A3 (fr) Kit ou dispositif de détection du cancer du poumon et procédé de détection
EP3816302A3 (fr) Kit ou dispositif de détection du cancer de l' sophage et procédé de détection
MX364886B (es) Lente oftálmica con sistema microfluídico.
EP4365602A3 (fr) Biomarqueur du cancer de l'estomac et procédé de détection
EA201001867A1 (ru) Зажим, предназначенный для захватывания держателя биологических проб, комплект компонентов, состоящий из держателя биологических проб и соответствующего зажима, и устройство для обработки и/или анализа
ATE554389T1 (de) Apex als marker für lungenkrebs
BR112013025329A2 (pt) identificar e enumerar células prematuramente granuladas (ecgs)
EP4328587A3 (fr) Utilisation d'un kit ou d'un dispositif et méthode de détection de la démence
EA201391627A1 (ru) Анализ на наличие лизилоксидазоподобных белков 2 и способы его применения
BR112018010764A2 (pt) método para detectar atividade bacteriana em uma amostra biológica e unidade de detecção correspondente
BR112022008217A2 (pt) Métodos e dispositivos para sequenciamento
MX2021004894A (es) Analisis de beta-caseina de leche y productos lacteos.
FR3034523B1 (fr) Nouvelle methode pour detecter la presence de bacteries productrices de beta-lactamases.
HK1136873A1 (en) Use of nnmt as a marker for lung cancer
EP4300101A3 (fr) Peptides antigéniques et leurs utilisations pour diagnostiquer et traiter l'autisme